Literature DB >> 20185440

Truth-telling in cancer: examining the cultural incompatibility argument in Turkey.

Tolga Guven1.   

Abstract

This article aims to examine critically the 'cultural incompatibility' argument, which asserts that disclosure of cancer-related information to patients is incompatible with Turkey's cultural context. For this purpose, a brief overview of the approach to truth-telling in Turkey will first be provided, followed by the claims of two different Turkish authors on the issue and a critical analysis of their approach. It will be contended that this argument has actually been formulated with paternalistic concerns and it may be playing an important role in shaping the approach of Turkish health care professionals to the issue. The article will then examine, in the light of study findings and case reports from Turkey, the concept of patient autonomy as it applies to truth-telling issues. It will be concluded that truth-telling can be compatible with Turkey's cultural context, provided that health care professionals place more emphasis on good communication with their patients.

Entities:  

Mesh:

Year:  2010        PMID: 20185440     DOI: 10.1177/0969733009352046

Source DB:  PubMed          Journal:  Nurs Ethics        ISSN: 0969-7330            Impact factor:   2.874


  3 in total

1.  Breaking bad news: current prospective and practical guideline for Muslim countries.

Authors:  Ahmed Salem; Abdel-Fattah Salem
Journal:  J Cancer Educ       Date:  2013-12       Impact factor: 2.037

2.  How do nurses support chronically ill clients' participation and self-management in primary care? A cross-country qualitative study.

Authors:  Kerstin Hämel; Gundula Röhnsch; Marcus Heumann; Dirce Stein Backes; Beatriz Rosana Gonçalves de Oliveira Toso; Ligia Giovanella
Journal:  BMC Prim Care       Date:  2022-04-18

3.  Muslim physicians and palliative care: attitudes towards the use of palliative sedation.

Authors:  George Muishout; Hanneke W M van Laarhoven; Gerard Wiegers; Ulrike Popp-Baier
Journal:  Support Care Cancer       Date:  2018-05-08       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.